Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
2025年1月7日 - 11:00PM
ビジネスワイヤ（英語）
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that it will participate in the 43rd
Annual J.P. Morgan Healthcare Conference in San Francisco, CA on
Wednesday, Jan. 15, 2025 at 9:00 a.m. PT (12:00 p.m. ET). Members
of management will deliver a presentation and host a Q&A with
the investment community at the conference.
A live webcast may be accessed through the investor relations
section of the Natera website at investor.natera.com. A replay of
the event will be available shortly following the conference.
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing,
dedicated to oncology, women’s health, and organ health. We aim to
make personalized genetic testing and diagnostics part of the
standard of care to protect health and inform earlier, more
targeted interventions that help lead to longer, healthier lives.
Natera’s tests are validated by more than 250 peer-reviewed
publications that demonstrate high accuracy. Natera operates ISO
13485-certified and CAP-accredited laboratories certified under the
Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas,
and San Carlos, California. For more information, visit
www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250107036377/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
650-249-9090, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera,
Inc., pr@natera.com
Natera (NASDAQ:NTRA)
過去 株価チャート
から 12 2024 まで 1 2025
Natera (NASDAQ:NTRA)
過去 株価チャート
から 1 2024 まで 1 2025
